216 related articles for article (PubMed ID: 29157727)
1. An opportunistic route to success: Towards a change of paradigm to fully exploit the potential of cell-penetrating peptides.
Collado Camps E; Brock R
Bioorg Med Chem; 2018 Jun; 26(10):2780-2787. PubMed ID: 29157727
[TBL] [Abstract][Full Text] [Related]
2. Cell penetration: scope and limitations by the application of cell-penetrating peptides.
Reissmann S
J Pept Sci; 2014 Oct; 20(10):760-84. PubMed ID: 25112216
[TBL] [Abstract][Full Text] [Related]
3. Applications and Challenges for Use of Cell-Penetrating Peptides as Delivery Vectors for Peptide and Protein Cargos.
Kristensen M; Birch D; Mørck Nielsen H
Int J Mol Sci; 2016 Jan; 17(2):. PubMed ID: 26840305
[TBL] [Abstract][Full Text] [Related]
4. On the biomedical promise of cell penetrating peptides: limits versus prospects.
Foerg C; Merkle HP
J Pharm Sci; 2008 Jan; 97(1):144-62. PubMed ID: 17763452
[TBL] [Abstract][Full Text] [Related]
5. The Current Role of Cell-Penetrating Peptides in Cancer Therapy.
Feni L; Neundorf I
Adv Exp Med Biol; 2017; 1030():279-295. PubMed ID: 29081059
[TBL] [Abstract][Full Text] [Related]
6. Cell-penetrating peptides: possibilities and challenges for drug delivery in vitro and in vivo.
Skotland T; Iversen TG; Torgersen ML; Sandvig K
Molecules; 2015 Jul; 20(7):13313-23. PubMed ID: 26205056
[TBL] [Abstract][Full Text] [Related]
7. A survey on "Trojan Horse" peptides: opportunities, issues and controlled entry to "Troy".
Shi NQ; Qi XR; Xiang B; Zhang Y
J Control Release; 2014 Nov; 194():53-70. PubMed ID: 25151981
[TBL] [Abstract][Full Text] [Related]
8. Rational design of CPP-based drug delivery systems: considerations from pharmacokinetics.
Mickan A; Sarko D; Haberkorn U; Mier W
Curr Pharm Biotechnol; 2014; 15(3):200-9. PubMed ID: 25312539
[TBL] [Abstract][Full Text] [Related]
9. In vivo biodistribution and efficacy of peptide mediated delivery.
Järver P; Mäger I; Langel Ü
Trends Pharmacol Sci; 2010 Nov; 31(11):528-35. PubMed ID: 20828841
[TBL] [Abstract][Full Text] [Related]
10. The pharmacokinetics of cell-penetrating peptides.
Sarko D; Beijer B; Garcia Boy R; Nothelfer EM; Leotta K; Eisenhut M; Altmann A; Haberkorn U; Mier W
Mol Pharm; 2010 Dec; 7(6):2224-31. PubMed ID: 20845937
[TBL] [Abstract][Full Text] [Related]
11. Nanocarriers Conjugated with Cell Penetrating Peptides: New Trojan Horses by Modern Ulysses.
Zappavigna S; Misso G; Falanga A; Perillo E; Novellino E; Galdiero M; Grieco P; Caraglia M; Galdiero S
Curr Pharm Biotechnol; 2016; 17(8):700-22. PubMed ID: 27087493
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic potential of cell-penetrating peptides.
Vasconcelos L; Pärn K; Langel U
Ther Deliv; 2013 May; 4(5):573-91. PubMed ID: 23647276
[TBL] [Abstract][Full Text] [Related]
13. Taming Cell Penetrating Peptides: Never Too Old To Teach Old Dogs New Tricks.
Zhang Q; Gao H; He Q
Mol Pharm; 2015 Sep; 12(9):3105-18. PubMed ID: 26237247
[TBL] [Abstract][Full Text] [Related]
14. Cell-penetrating peptides: a useful tool for the delivery of various cargoes into cells.
Böhmová E; Machová D; Pechar M; Pola R; Venclíková K; Janoušková O; Etrych T
Physiol Res; 2018 Oct; 67(Suppl 2):S267-S279. PubMed ID: 30379549
[TBL] [Abstract][Full Text] [Related]
15. Cell-penetrating peptide exploited syndecans.
Letoha T; Keller-Pintér A; Kusz E; Kolozsi C; Bozsó Z; Tóth G; Vizler C; Oláh Z; Szilák L
Biochim Biophys Acta; 2010 Dec; 1798(12):2258-65. PubMed ID: 20138023
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic delivery opportunities, obstacles and applications for cell-penetrating peptides.
Lindberg S; Copolovici DM; Langel U
Ther Deliv; 2011 Jan; 2(1):71-82. PubMed ID: 22833926
[TBL] [Abstract][Full Text] [Related]
17. On the importance of electrostatic interactions between cell penetrating peptides and membranes: a pathway toward tumor cell selectivity?
Jobin ML; Alves ID
Biochimie; 2014 Dec; 107 Pt A():154-9. PubMed ID: 25107405
[TBL] [Abstract][Full Text] [Related]
18. Cell-Penetrating Peptides: Design Strategies beyond Primary Structure and Amphipathicity.
Kalafatovic D; Giralt E
Molecules; 2017 Nov; 22(11):. PubMed ID: 29117144
[TBL] [Abstract][Full Text] [Related]
19. Cell-penetrating peptides as tools to enhance non-injectable delivery of biopharmaceuticals.
Kristensen M; Nielsen HM
Tissue Barriers; 2016; 4(2):e1178369. PubMed ID: 27358757
[TBL] [Abstract][Full Text] [Related]
20. Recent Advances of Studies on Cell-Penetrating Peptides Based on Molecular Dynamics Simulations.
Ouyang J; Sheng Y; Wang W
Cells; 2022 Dec; 11(24):. PubMed ID: 36552778
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
